NAPSA and carcinoma: Furthermore, in our study, 47.2% of TTF-1 and/or Napsin A positive PSCGC carcinoma were positive for PD-L1 whereas only 27.8% of TTF-1and/or Napsin A negative were positive for PD-L1.